MarketPeel
Insider Trading Intelligence
EVP R&D, Chief Medical Officer
Mon, Aug 3, 2026
17d ago
sold $437.22k of ALKS
9,000 shares @ $48.58
Decreased holdings by -11.50%
20th largest trade (out of 157)
Planned (10b5-1)
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025.Form 4 footnote
Trade made by an officer
Executed under a pre-scheduled Rule 10b5-1 plan
Price 39% above 200-day moving average
ALKSAlkermes plc.
Health CarePharmaceuticals
1D0.00%
1W+1.48%
1M-5.05%
3M+36.36%
6M
1Y

Recent insider activity at ALKS

FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback